We are republishing this in the Authors name after clarifying her good intentions, as some readers raised concern about the use of their data.
DRUG manufacturers, regulatory bodies and global governments do not know the long-term safety profile of the rapidly developed, experimental SARS-CoV-2 vaccines that they are heavily promoting and, in some cases, mandating to the world’s citizens, including children. The Emergency Use Authorised vaccines are still in trial until 2023, but most of the initial phase 1 and 2 trial control groups have now been unblinded and offered a vaccination. Without an ongoing robust, unvaccinated control group, essential long-term safety information will be difficult or impossible to discover.
The need for a co-operation of independent scientists and medics, concerned citizens and community groups with no single vested interests, collaborating globally, has never been more critical.
The Vaccine Control Group is a citizen-led registry, run by VaxControlGroup Cooperative Ltd, that offers the unvaccinated the opportunity to volunteer to be part of this essential control group and confidentially offer their medical history and any future medical diagnosis.
The baseline data gathered through maintenance of this large, global, unvaccinated control group will be available to any researcher worldwide for comparison with the vaccinated cohort for future investigation; systemic adverse reactions, adverse events, non-serious adverse event, serious adverse events, medically attended adverse events, new onset medical conditions, fertility and any other health issue of any degree or type arising or exacerbated post-vaccination, whether suspected, unexpected, expected or otherwise, and whether or not considered as related to the vaccines.
Participants can support the study by becoming an Associate and they will receive an ID card as proof of registry to protect against discrimination and coercion.
For an individual, the rationale for receiving these experimental vaccines depends on their safety and efficacy. According to a study in the Lancet, efficacy is much lower than the 90 per cent reported when assessing absolute risk reduction (ARR) rather than relative risk reduction (RRR): ‘The absolute risk reduction, which is the difference between attack rates with and without a vaccine, considers the whole population. ARRs tend to be ignored because they give a much less impressive effect size than RRRS: 1.3 per cent for the AstraZeneca-Oxford, 1.2 per cent for the Moderna-NIH, 1.2 per cent for the J&J, 0.93 per cent for the Gamaleya, and 0.84 per cent for the Pfizer-BioNTech vaccine.’ Real world data from Israel suggests the Pfizer vaccine to be 60 per cent effective. To give informed consent the risk of vaccine side effects needs to be weighed against the risk of the disease and the efficacy of vaccine. Currently this equation is difficult to balance without accurate safety data.
Everyone has the right to medical freedom, and informed consent is enshrined in the Nuremburg Code and international law. Many people, particularly those in groups most vulnerable to severe symptoms of Covid-19, may be happy to receive a SARS-CoV-2 vaccine. Others may wish to wait for multiple reasons, such as: natural immunity having recovered from Covid-19, deferring until trials end in 2023 in order to assess safety, underlying health conditions not included in phase 1/2 trials such as autoimmune diseases and pregnancy, religious or other objections to vaccination or the ingredients used, and assessing that risk vs benefit ratio is not favourable for their demographic.
The VaxControlGroup will never coerce, influence or promote non-vaccination; it merely seeks to provide a baseline database for future comparison between vaccinated vs voluntarily unvaccinated groups with those who have made the decision to delay or not vaccinate against SARS-CoV-2. It is unethical and illegal to discriminate against people who have freely chosen not to be vaccinated.
All data gathered is encrypted, anonymous and secure. Only email used as an identifier.
You can register here.